10:00 ET -- Moderna Inc. is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The biotechnology company on Tuesday gave its annual update on its vaccines portfolio, including reporting that its first influenza vaccine candidate didn't meet the criterial for early success in a Phase 3 trial. Moderna shares are down 5.3%. Dow Jones & Co. owns Factiva. (colin.kellaher@wsj.com)

(END) Dow Jones Newswires

April 11, 2023 10:15 ET (14:15 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Moderna (NASDAQ:MRNA)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024 Click aqui para mais gráficos Moderna.
Moderna (NASDAQ:MRNA)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024 Click aqui para mais gráficos Moderna.